Cutler Group LP Spectrum Pharmaceuticals Inc Call Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Oct 25, 2022	SELL	$0.43 - $1.56 $344 - $1,248	-800 Reduced 14.81%	4,600 $0
Q2 2022 Aug 04, 2022	SELL	$0.7 - $1.4 $5,180 - $10,360	-7,400 Reduced 57.81%	5,400 $1,000
Q1 2022 Apr 14, 2022	BUY	$0.63 - $1.59 $8,064 - $20,352	12,800 New	12,800 $4,000
Q4 2018 Feb 05, 2019	SELL	$6.39 - $16.99 $6,390 - $16,990	-1,000 Closed	0 $0
Q3 2018 Nov 07, 2018	SELL	$16.52 - $24.82 $284,144 - $426,904	-17,200 Reduced 94.51%	1,000 $0
Q2 2018 Aug 10, 2018	BUY	$14.31 - $21.75 $257,580 - $391,500	18,000 Added 9000.0%	18,200 $38,000
Q4 2017 Jan 17, 2018	BUY	$13.36 - $20.73 $2,672 - $4,146	200	200 $0

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.